NR1I3 and neoplasm: Despite the strong evidence for CAR and/or PXR activation in cellular systems, these compound classes have mostly been investigated in animal studies for their hepatotoxic or tumor-promoting properties related to CAR (e.g., [87]) without a major focus on metabolic changes.